Form N-2 - Registration statement for closed-end investment companies:
SEC Accession No. 0001341004-16-001294
Filing Date
2016-04-15
Accepted
2016-04-15 13:55:52
Documents
9

Document Format Files

Seq Description Document Type Size
1 N-2 n-2.htm N-2 2246075
2 EXHIBIT (R)(1) - CODE OF ETHICS OF THE REGISTRANT exr1.htm EX-99.2R CODE ETH 270367
3 EXHIBIT (S)(1) - POWER OF ATTORNEY exs1.htm EX-99.16 PWR OF ATTY 29438
4 EXHIBIT (S)(2) - POWER OF ATTORNEY exs2.htm EX-99.16 PWR OF ATTY 9749
6 ishares_byblackrock.jpg GRAPHIC 6968
7 ishares_sm.jpg GRAPHIC 4801
8 logo.jpg GRAPHIC 7188
9 logo-small.jpg GRAPHIC 4329
10 filename10.htm CORRESP 21583
  Complete submission text file 0001341004-16-001294.txt   2611222
Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2 | Act: 33 | File No.: 333-210770 | Film No.: 161573961

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 (888) 825-2257
BlackRock Health Sciences Trust (Filer) CIK: 0001314966 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: N-2 | Act: 40 | File No.: 811-21702 | Film No.: 161573962